IL87413A0 - Elaboration of host defense mediators into biological fluids by systemic dsrna treatment - Google Patents

Elaboration of host defense mediators into biological fluids by systemic dsrna treatment

Info

Publication number
IL87413A0
IL87413A0 IL87413A IL8741388A IL87413A0 IL 87413 A0 IL87413 A0 IL 87413A0 IL 87413 A IL87413 A IL 87413A IL 8741388 A IL8741388 A IL 8741388A IL 87413 A0 IL87413 A0 IL 87413A0
Authority
IL
Israel
Prior art keywords
biological fluids
elaboration
host defense
various
systemic
Prior art date
Application number
IL87413A
Other languages
English (en)
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of IL87413A0 publication Critical patent/IL87413A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL87413A 1987-08-12 1988-08-11 Elaboration of host defense mediators into biological fluids by systemic dsrna treatment IL87413A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422787A 1987-08-12 1987-08-12

Publications (1)

Publication Number Publication Date
IL87413A0 true IL87413A0 (en) 1989-01-31

Family

ID=22183617

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87413A IL87413A0 (en) 1987-08-12 1988-08-11 Elaboration of host defense mediators into biological fluids by systemic dsrna treatment

Country Status (19)

Country Link
EP (1) EP0308066B1 (xx)
JP (1) JPH01131119A (xx)
KR (1) KR0131879B1 (xx)
CN (1) CN1050995C (xx)
AT (1) ATE132041T1 (xx)
AU (3) AU2053588A (xx)
CA (1) CA1327002C (xx)
DE (1) DE3854829T2 (xx)
DK (1) DK449888A (xx)
FI (1) FI883763A (xx)
HU (1) HUT47854A (xx)
IE (1) IE72103B1 (xx)
IL (1) IL87413A0 (xx)
NO (1) NO883594L (xx)
NZ (1) NZ225799A (xx)
OA (1) OA08901A (xx)
PT (1) PT88266B (xx)
RU (1) RU1834663C (xx)
ZA (1) ZA885967B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
DE3853755T2 (de) * 1987-09-04 1995-12-14 Hem Pharma Corp Diagnose von Mangelzuständen doppelsträngiger RNS.
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
JPH02504429A (ja) * 1988-05-23 1990-12-13 ガイ，ステファン リウマチ様関節炎の診断と治療
JPH04507083A (ja) * 1989-05-19 1992-12-10 ヘム・リサーチ・インコーポレーテッド 規定された構造の短い治療用ｄｓＲＮＡ
ATE147630T1 (de) * 1989-10-11 1997-02-15 Hem Pharma Corp Schutz gegen schock infolge einer schädigung durch doppelsträngige rna's
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
AU647754B2 (en) * 1989-10-16 1994-03-31 Hem Research, Inc. Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
AU2554792A (en) * 1991-09-26 1993-04-27 Hem Pharmaceuticals Corp. Method of neutralizing il-1 using dsrnas
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
ATE526406T1 (de) 1998-03-20 2011-10-15 Commw Scient Ind Res Org Kontrolle der genexpression
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP1147204A1 (en) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
CA2369944A1 (en) 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
MXPA04010282A (es) 2002-04-18 2005-08-18 Acuity Pharmaceuticals Inc Medios y metodos para la inhibicion especifica de genes en celulas y tejido de cns y/u ojo.
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
US20060030534A1 (en) 2002-09-04 2006-02-09 Gabriele Dorn Treatment of neurological disorders by dsrna administration
BRPI0808637A2 (pt) * 2007-03-05 2014-08-05 Univ Utah State Agonista restritivo do receptor 3 similar a toll (tlr3)
EP2361306A1 (en) 2008-12-04 2011-08-31 OPKO Ophthalmics, LLC Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
CN109355334A (zh) * 2018-12-06 2019-02-19 江苏省农业科学院 一种制备聚肌胞的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
EP0308066A3 (en) 1991-01-16
DE3854829T2 (de) 1996-08-14
NZ225799A (en) 1991-04-26
PT88266B (pt) 1995-05-04
JPH01131119A (ja) 1989-05-24
DK449888D0 (da) 1988-08-11
ZA885967B (en) 1989-07-26
CN1032740A (zh) 1989-05-10
EP0308066B1 (en) 1995-12-27
PT88266A (pt) 1989-06-30
FI883763A0 (fi) 1988-08-12
CA1327002C (en) 1994-02-15
RU1834663C (ru) 1993-08-15
KR0131879B1 (ko) 1998-04-17
OA08901A (en) 1989-10-31
EP0308066A2 (en) 1989-03-22
ATE132041T1 (de) 1996-01-15
IE882399L (en) 1989-02-12
AU2053588A (en) 1989-04-20
NO883594D0 (no) 1988-08-12
HUT47854A (en) 1989-04-28
FI883763A (fi) 1989-02-13
AU1736792A (en) 1992-07-30
NO883594L (no) 1989-02-13
DE3854829D1 (de) 1996-02-08
KR890003402A (ko) 1989-04-14
IE72103B1 (en) 1997-03-12
DK449888A (da) 1989-02-13
AU1001595A (en) 1995-02-23
CN1050995C (zh) 2000-04-05

Similar Documents

Publication Publication Date Title
OA08901A (en) Elaboration of host defense mediators into biological fluids by systemic DSRNA treatment.
BR9004130A (pt) Virus ou bacteriofagos contra o crescimento de micro-organismos indesejaveis a composicao para combate a micro-organismos indesejaveis
ATE87214T1 (de) Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).
DK345484A (da) Projektil til ildvaaben
EP0500893A4 (en) Preservation of blood, tissues and biological fluids
EP0221611A3 (en) Antimicrobial agents and process for their manufacture
BR0112919A (pt) Uso de óleos essenciais para combater infecção do trato gi por organismos semelhantes a helicobacter
GR3022801T3 (en) Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity.
AU5684286A (en) Use of an aqueous, stabilised chlorite matrix solution for infectious conditions
ES2053039T3 (es) Procedimiento para impedir el cambio de color de los alimentos.
WO1987000751A3 (fr) Utilisation d'acides carboxyliques d'oxirane pour le traitement de l'hyperlipemie
DK178188A (da) Antivirusmiddel
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
ES2046246T3 (es) Composicion terapeutica para combatir el sida.
KR900017587A (ko) 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도
DE69110470D1 (de) Herstellung von erhöhten Biokontrollwirkstoffen.
SU1727820A1 (ru) Способ стимул ции сперматогенеза у быков
Ohbuchi Negativity Bias
AU4849897A (en) Elaboration of host defense mediators into biological fluids by systemic dsRNA treatment
PT83247B (pt) Processo para a preparacao de hidroxialquil-fenoxi-propan-2-olaminas uteis como beta-bloqueadores oculosselectivos
Pavlovskis et al. Experimental Pseudomonas aeruginosa infections in burned mice and rats: Description of a model.
RU92015278A (ru) Средство, стабилизирующее витамины групп с, р, в и а и повышающее биологическую ценность пищевых продуктов
RU95116072A (ru) Способ повышения иммунологической защиты организма при смешанной инфекции ожоговой травмы
Kosmidis TREATMENT OF SERIOUS INFECTIONS WITH CEFTRIAXONE
TW251235B (en) Treatment of viral infections

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees